Sfoglia per AUTORE
PORTA C
Collezione AO Ordine Mauriziano

  

Items : 5

Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients. in ESMO open / ESMO Open. 2023 Dec;8(6):102192. doi: 10.1016/j.esmoop.2023.102192. Epub 2023 Dec 5.

2023
AO Ordine Mauriziano

Frontini L; Giannarelli D; Arenare L; Porta C; Barberio D; Terzolo S; Zagonel V; Pisconti S; Del Mastro L; Gallo C; Di Maio M; Riva S; Efficace F; Jommi C; Piccirillo MC; Bryce J; Vaccaro MC; Gitto L; Traclò F; Iannelli E; De Lorenzo F; Del Campo L; Montesarchio V; Migliaccio G; Rizzo M; Cinieri S; Bilancia D; Pinto C; Perrone F; et alii...

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The ?-Meet-URO analysis. in Frontiers in oncology / Front Oncol. 2022 Sep 23;12:955501. doi: 10.3389/fonc.2022.955501. eCollection 2022.

2022
ASL Cuneo 2
AO Ordine Mauriziano

Buti S; Fornarini G; Banna GL; Porta C; Llaja Obispo MA; Roviello G; Cavo A; Vignani F; Nolè F; Caffo O; Messina M; Morelli F; Prati G; Soto Parra HJ; Atzori F; Di Napoli M; Santoni M; Cortellini A; Prati V; Massari F; Sorarù M; Panni S; Fratino L; Sabbatini R; Ricotta R; Boccardo F; Milella M; Procopio G; Zucali PA; et alii...

Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system. in BMJ open / BMJ Open. 2021 Oct 20;11(10):e049128. doi: 10.1136/bmjopen-2021-049128.

2021
AO Ordine Mauriziano

Riva S; Arenare L; Di Maio M; Efficace F; Montesarchio V; Frontini L; Giannarelli D; Bryce J; Del Campo L; De Lorenzo F; Iannelli E; Traclò F; Gitto L; Jommi C; Vaccaro CM; Barberio D; Cinieri S; Porta C; Del Mastro L; Zagonel V; Cogoni AA; Bordonaro R; Gimigliano A; Piccirillo MC; Guizzaro L; Gallo C; Perrone F;

Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2021 May 18;13:17588359211019642. doi: 10.1177/17588359211019642. eCollection 20

2021
AO Ordine Mauriziano
ASL Cuneo 2

Buti S; Porta C; Perrino M; Brunelli M; Iacovelli R; Paolieri F; Chiellino S; Bersanelli M; Casadei C; Cavo A; Roviello G; Pierantoni F; Prati G; Vignani F; Nolè F; Morelli F; Messina M; Pignata S; Messina C; Stellato M; Atzori F; Soto Parra HJ; Cortellini A; Prati V; Sorarù M; Santoni M; Mollica V; Panni S; Fratino L; et alii...

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey. in PloS one / PLoS One. 2013 Dec 30;8(12):e83026. doi: 10.1371/journal.pone.0083026. eCollection 2013.

2013
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Sabbatini R; Maiello E; Adamo V; Tanca FM; Fedeli SL; Badalamenti G; Russo A; Collovà E; Satolli MA; Silvestris N; Santoni M; Virzì V; Lanzetta G; Carteni G; Ottaviani D; Ortega C; Vincenzi B; Berardi R; Berruti A; Fontana A; Mazzara C; Barni S; Porta C; Ibrahim T; Procopio G; Santini D; Felici A; Cinieri S; Tonini G; et alii...